Establishment and characterisation of a new patient-derived model of myxoid liposarcoma with acquired resistance to trabectedin-Reference-Cited by-同舟云学术

Establishment and characterisation of a new patient-derived model of myxoid liposarcoma with acquired resistance to trabectedin

Published:2019-08-14 Issue:6 Volume:121 Page:464-473
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Bello Ezia,Brich Silvia,Craparotta Ilaria,Mannarino Laura,Ballabio Sara,Gatta Raffaella,Marchini Sergio,Carrassa Laura,Matteo Cristina,Sanfilippo Roberta,Gronchi Alessandro^ORCID,Casali Paolo Giovanni,Pilotti Silvana,D’Incalci Maurizio,Frapolli Roberta

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/s41416-019-0550-2.pdf

Reference31 articles.

1. De Vita, A., Mercatali, L., Recine, F., Pieri, F., Riva, N., Bongiovanni, A. et al. Current classification, treatment options, and new perspectives in the management of adipocytic sarcomas. Onco.Targets Ther. 9, 6233–6246 (2016).

2. Sandberg, A. A. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: liposarcoma. Cancer Genet. Cytogenet. 155, 1–24 (2004).

3. Jones, R. L., Fisher, C., Al-Muderis, O. & Judson, I. R. Differential sensitivity of liposarcoma subtypes to chemotherapy. Eur. J. Cancer. 41, 2853–2860 (2005).

4. Grosso, F., Jones, R. L., Demetri, G. D., Judson, I. R., Blay, J.-Y., Le Cesne, A. et al. Efficacy of trabectedin (ecteinascidin-743) in advanced pretreated myxoid liposarcomas: a retrospective study. Lancet Oncol. 8, 595–602 (2007).

5. Grosso, F., Sanfilippo, R., Virdis, E., Piovesan, C., Collini, P., Dileo, P. et al. Trabectedin in myxoid liposarcomas (MLS): a long-term analysis of a single-institution series. Ann. Oncol. 20, 1439–1444 (2009).

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic strategies of targeting non-apoptotic regulated cell death (RCD) with small-molecule compounds in cancer;Acta Pharmaceutica Sinica B;2024-07

2. Long-term efficacy of eribulin in patients with advanced myxoid liposarcoma resistant to trabectedin: A case report;JOS Case Reports;2024-06

3. Quantitative measurement of pioglitazone in neoplastic and normal tissues by AP-MALDI mass spectrometry imaging;Talanta;2022-01

4. Mechanisms of responsiveness to and resistance against trabectedin in murine models of human myxoid liposarcoma;Genomics;2021-09

5. Eribulin Provides a Remarkable Effect in Trabectedin-Resistant Myxoid Liposarcoma;Case Reports in Orthopedics;2020-11-12